(TCH) Docetaxel, Trastuzumab and Pertuzumab
(DOH-see-TAK-sil, tras-TU-zoo-mab and per-TU-zoo-mab)
Taxotere®, Herceptin® and Perjeta®
This regimen is most commonly used to treat human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer, but may be used for other treatments.
Our Medication Sheet
This sheet is available to download as an Adobe PDF.Get TCH Medication Sheet